We are live on ! Find out more
Mackenzie Financial

Mackenzie Financial Portfolio holdings

AUM $100B
1-Year Est. Return 36.93%
This Fund
S&P 500
This Quarter Est. Return
+0.48%
1 Year Est. Return
+36.93%
3 Year Est. Return
+93.95%
5 Year Est. Return
+113.13%
10 Year Est. Return
+336.84%
AUM
$67.3B
AUM Growth
-$2.09B
Cap. Flow
-$1.26B
Cap. Flow %
-1.88%
Top 10 Hldgs %
22.59%
Holding
1,667
New
146
Increased
574
Reduced
656
Closed
131

Top Sells

Rank Stock Value
1
GLD icon
SPDR Gold Trust
GLD
+$241M
2
AON icon
Aon
AON
+$160M
3
BMO icon
Bank of Montreal
BMO
+$157M
4
TU icon
Telus
TU
+$129M
5
CPRT icon
Copart
CPRT
+$126M

Sector Composition

Rank Sector Weight
1 Technology 21.36%
2 Financials 20.78%
3 Industrials 12.2%
4 Healthcare 9.16%
5 Energy 7.93%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake
Capital Flow
SNAP icon
676
Snap
SNAP
$9.86B
$2.61M ﹤0.01%
156,838
+8,714
+6% +$125K
IPG
677
DELISTED
Interpublic Group of Companies
IPG
$2.58M ﹤0.01%
88,525
-540
-0.6% -$16.6K
RGA icon
678
Reinsurance Group of America
RGA
$16.2B
$2.57M ﹤0.01%
12,543
-1,263
-9% -$252K
LBTYK icon
679
Liberty Global Class C
LBTYK
$3.44B
$2.57M ﹤0.01%
143,945
-740,769
-84% -$12.9M
FITB
680
Fifth Third Bancorp
FITB
$49.6B
$2.55M ﹤0.01%
69,978
-6,499
-8% -$237K
AVTR icon
681
Avantor
AVTR
$10.4B
$2.55M ﹤0.01%
120,428
-1,509
-1% -$36.3K
VYX icon
682
NCR Voyix
VYX
$1.04B
$2.55M ﹤0.01%
206,550
+128,660
+165% +$1.62M
XRAY icon
683
Dentsply Sirona
XRAY
$1.96B
$2.54M ﹤0.01%
101,876
+12,578
+14% +$361K
BMRN icon
684
BioMarin Pharmaceuticals
BMRN
$12.5B
$2.51M ﹤0.01%
30,474
+4,832
+19% +$402K
ACIW icon
685
ACI Worldwide
ACIW
$5.18B
$2.49M ﹤0.01%
62,958
+2,879
+5% +$100K
VALE icon
686
Vale
VALE
$61.6B
$2.45M ﹤0.01%
219,700
-1,671,317
-88% -$20.1M
PFG icon
687
Principal Financial Group
PFG
$25.3B
$2.45M ﹤0.01%
31,278
-853
-3% -$69.3K
ANSS
688
DELISTED
Ansys
ANSS
$2.45M ﹤0.01%
7,614
-328
-4% -$107K
PRDO icon
689
Perdoceo Education
PRDO
$2.06B
$2.45M ﹤0.01%
114,235
-7,175
-6% -$149K
WST icon
690
West Pharmaceutical
WST
$25.7B
$2.41M ﹤0.01%
7,329
-318
-4% -$112K
CIEN icon
691
Ciena
CIEN
$47.4B
$2.41M ﹤0.01%
50,062
+41,580
+490% +$1.97M
VZLA
692
Vizsla Silver
VZLA
$1.34B
$2.39M ﹤0.01%
1,352,599
EFOR
693
Everforth Inc
EFOR
$1.39B
$2.37M ﹤0.01%
26,884
+23,764
+762% +$2.27M
ESNT icon
694
Essent Group
ESNT
$6.13B
$2.35M ﹤0.01%
41,814
-7,007
-14% -$390K
MSTR icon
695
Strategy Inc
MSTR
$51.5B
$2.35M ﹤0.01%
17,050
+8,010
+89% +$1.15M
CAG icon
696
Conagra Brands
CAG
$7.21B
$2.34M ﹤0.01%
82,408
-5,269
-6% -$158K
TRMB icon
697
Trimble
TRMB
$13.7B
$2.33M ﹤0.01%
41,586
+21,088
+103% +$1.22M
DOV icon
698
Dover
DOV
$25.5B
$2.29M ﹤0.01%
12,666
-101
-0.8% -$18.1K
TER icon
699
Teradyne
TER
$52B
$2.28M ﹤0.01%
15,358
-34,731
-69% -$4.41M
MOH icon
700
Molina Healthcare
MOH
$10.8B
$2.27M ﹤0.01%
7,641
+1,384
+22% +$470K

Similar funds

Mackenzie Financial's Q2 2024 Portfolio in Review

As of Q2 2024, Mackenzie Financial held 1,667 positions worth $67.3B, down 3% from $69.4B the previous quarter. Its ten largest holdings account for 23% of the portfolio.

Mackenzie Financial's Q2 2024 filing shows 146 new, 574 increased, 656 reduced and 131 closed positions. Its largest new stake was DoubleVerify: 2,722,926 shares worth $53M. The largest sale was SPDR Gold Trust, an estimated $241M.

By sector, the portfolio is most concentrated in Technology at 21% of assets, up from 20% a quarter earlier, followed by Financials and Industrials.

  • Mackenzie Financial's largest Q2 2024 buy was DoubleVerify: 2,722,926 shares worth $53M.
  • Mackenzie Financial added most to ExxonMobil in Q2 2024, an estimated $187M increase.
  • Mackenzie Financial's biggest Q2 2024 reduction was SPDR Gold Trust, cutting an estimated $241M.
  • Mackenzie Financial fully exited iShares US Medical Devices ETF in Q2 2024, selling an estimated $15.7M.
  • Mackenzie Financial's ten largest holdings make up 23% of its $67.3B portfolio in Q2 2024.
  • Mackenzie Financial opened 146 new positions and closed 131 in Q2 2024.
  • Mackenzie Financial's portfolio value fell 3% quarter-over-quarter to $67.3B.

Based on Mackenzie Financial's 13F filing for Q2 2024, filed 14 Aug 2024.